Alpha Cognition Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, primarily Alzheimer's disease. Its lead product, ZUNVEYL (benzgalantamine), is an FDA-approved next-generation acetylcholinesterase inhibitor for mild-to-moderate Alzheimer's disease in adults, commercially launched on March 19, 2025, targeting the long-term care market. The company also has pre-clinical programs including ZUNVEYL in combination with memantine, ALPHA-1062 sublingual formulation for mTBI and acute pancreatitis, and previously held Progranulin-related assets for ALS and SMA.
Q2 FY2026 — expected 2026-08-22
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001213900-26-037614 | EDGAR | 105K words |
| 2025-03-31 | 2024-12-31 | 0001213900-25-026225 | EDGAR | 104K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001213900-26-089188 | EDGAR | 24K words |
| 2025-11-13 | 2025-09-30 | 0001213900-25-110061 | EDGAR | 23K words |
| 2025-08-14 | 2025-06-30 | 0001213900-25-076600 | EDGAR | 26K words |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044163 | EDGAR | 31K words |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098409 | EDGAR | 37K words |
| 2024-08-12 | 2024-06-30 | 0001213900-24-067658 | EDGAR | 32K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001213900-26-035696 | EDGAR | 1K words |
| 2026-03-26 | 0001213900-26-034778 | EDGAR | 4K words |
| 2026-02-23 | 0001213900-26-019355 | EDGAR | 1K words |
| 2026-01-15 | 0001213900-26-004765 | EDGAR | 1K words |
| 2025-10-14 | 0001213900-25-098739 | EDGAR | 1K words |
| 2025-10-02 | 0001213900-25-094911 | EDGAR | 1K words |
| 2025-08-22 | 0001213900-25-080012 | EDGAR | 1K words |
| 2025-06-23 | 0001213900-25-056752 | EDGAR | 1K words |
| 2025-04-10 | 0001213900-25-030683 | EDGAR | 1K words |
| 2025-02-27 | 0001213900-25-018138 | EDGAR | 2K words |
51 total filings indexed. 33 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001655923 |
| Ticker | ACOG |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | A1 |
| Website | https://www.alphacognition.com |
| Listed | 2021-06-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ACOG (~200 tokens, structured JSON with cryptographic provenance)